More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

Health insurer Cigna (CI) announced a new deal for copay caps on Eli Lilly (LLY) and Novo Nordisk (NVO) weight loss drugs. The deal caps copays at $200 a month through employer healthcare programs.

Cigna’s (NYSE: CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers to some questions consumers have.

STAT+: Pharmalittle: We're reading about rising drug prices, Cigna's plan for weight loss drugs, and more by STAT Follow Add Comment ...

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company's pharmacy benefits unit Evernorth ...

The cost of weight loss drugs is finally dropping. How low can prices go? Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Only half of health insurer Cigna 's clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs.